You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 19, 2025

Profile for Peru Patent: 20151600


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Peru Patent: 20151600

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Nov 21, 2034 Novartis Pharms Corp JADENU deferasirox
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Peru Patent PE20151600

Last updated: July 30, 2025

Introduction

Peru Patent PE20151600 pertains to a pharmaceutical patent, which plays a critical role in safeguarding innovative drug formulations and manufacturing processes within the Peruvian jurisdiction. This patent's scope, claims, and positioning within the local and global patent landscape determine its strategic value for the innovator, potential generic entrants, and stakeholders in the pharmaceutical sector. This analysis offers a comprehensive review, emphasizing patent scope, claim structure, and the landscape implications in Peru and internationally.


Patent Overview

Patent Number: PE20151600
Filing Date: Typically aligned with the application date registered with INDECOPI (Peru's National Institute for the Defense of Competition and the Protection of Intellectual Property).
Publication Date: Corresponds to patent grant publication.
Status: Active, granted (assuming this based on the patent number).
Applicant/Assignee: Usually a pharmaceutical innovator or a research-based entity.
Patent Type: Likely a compound patent or a formulation patent, depending on the technical subject matter.


Scope and Nature of the Patent

Technical Field and Purpose

PE20151600 likely relates to a specific pharmaceutical compound, its formulation, or a novel method of production. Given the standard scope of such patents, the primary focus likely involves:

  • A novel active pharmaceutical ingredient (API) or a unique combination.
  • A specific formulation that enhances bioavailability, stability, or patient compliance.
  • A proprietary manufacturing process that improves efficiency or purity.

Claims Structure and Prior Art Considerations

Peruvian patent practice aligns with international standards, referencing claims that define the scope of protection explicitly. The patent’s claims are critical for determining enforceability and the breadth of exclusivity.

  • Independent claims likely cover the core inventive concept—e.g., the chemical structure of a compound, unique process, or formulation.
  • Dependent claims narrow the scope, adding specific embodiments, dosage forms, or method steps.

In terms of claim language, typically, broad claims protect the fundamental invention, while narrower claims refine or specify particular aspects, such as particular salts, polymorphs, or delivery mechanisms.

Scope Analysis

Based on its patent number referencing standard pharmaceutical patenting strategies, its scope can generally be summarized as:

  • Chemical Scope: Covering a novel API, possibly a specific chemical derivative or an active metabolite.
  • Formulation Scope: Covering specific dosage forms like tablets, capsules, or injectables that incorporate the API.
  • Method Claims: Encompassing preparation procedures, purification steps, or delivery methods.
  • Use Claims: Including particular medical indications or therapeutic uses of the drug.

The scope's breadth directly influences market exclusivity, especially regarding generic entry, with broader claims providing more robust protection.


Claim Analysis

Key Elements of the Claims

While the claims are proprietary and detailed scrutiny requires examination of the full patent document, standard practice can infer:

  • Core Chemical Claims: Covering the compound's chemical structure or a closely related set of derivatives.
  • Pharmaceutical Composition Claims: Covering formulations combining the compound with excipients or carriers.
  • Manufacturing Claims: Covering specific steps or processes to synthesize or formulate the drug.
  • Therapeutic Claims: Covering methods of treatment for specific diseases or medical conditions.

Strength and Vulnerability of Claims

  • Broad Claims: If the patent claims encompass a wide range of derivatives or formulations, it provides extensive protection but may be vulnerable during patent examination and potential for invalidation if prior art is found.

  • Narrow Claims: Restricted to specific compounds or processes, offering limited protection but enhanced defensibility.

Claim Novelty and Inventive Step

  • The patent likely claims a novel chemical entity or a non-obvious formulation, satisfying novelty and inventive step criteria under Peruvian law, which aligns with international standards.

Patent Landscape in Peru and Globally

Peru’s Pharmaceutical Patent Environment

Peru’s patent system, governed by Ley No. 29459 and complemented by TRIPS obligations, ensures patent protection for drug inventions. Key aspects include:

  • Patent Term: 20 years from filing, with possible extensions.
  • Patentability Criteria: Novelty, inventive step, industrial applicability.
  • Compulsory Licensing: Peru permits licensing under defined conditions, which can impact patent strategy.

Local Patent Landscape

  • Major Players: Multinational pharmaceutical companies hold active patents, including those related to innovative drug compounds or formulations.
  • Generic Competition: Several patents for established drugs have expired or are under challenge, enabling generic entry.
  • Patent Clusters: Peru’s pharmaceutical patenting activity is concentrated around certain therapeutic areas like cardiovascular, anti-infectives, and oncological drugs.

Global Patent Landscape

  • Patent Families: The patent likely belongs to an international patent family, with applications in jurisdictions like the US, Europe, China, or Brazil, providing broader protection.
  • Patent Holdings: Large pharmaceutical entities often secure patent families for key compounds to block generics across multiple markets.
  • Litigation and Challenges: Active patent challenge climate exists in regions with high generic activity, emphasizing the importance of claim scope.

Patent Landscape Implications for PE20151600

  • Protection Strategy: The patent's enforceability depends on the scope vis-à-vis existing patents.
  • Freedom to Operate (FTO): Careful landscape analysis necessary before commercial introduction to avoid infringement.
  • Potential Infringements: Other patents possibly cover similar compounds or formulations; any overlapping claim scope could lead to litigation.

Legal and Commercial Considerations

  • Patent Validity: Ensuring the claims are supported by inventive activity and novelty as per Peruvian patent law.
  • Patent Infringement: Competitors may attempt to design around claims; a detailed claim map comparison is critical.
  • Patent Expiry: The patent protection lasts 20 years from filing, with potential extensions depending on local laws.

Conclusion

Peru Patent PE20151600 exemplifies a targeted pharmaceutical innovation, with scope likely centered on a specific chemical compound, formulation, or process. Its claims define a protected territorial market, with scope influenced by claim breadth and patent strategies. The legal landscape underscores the importance of ongoing patent prosecution, vigilant FTO assessments, and strategic patent portfolio development.


Key Takeaways

  • Claim Scope Optimization: Broad, well-structured claims afford stronger protection but require meticulous drafting to withstand validity challenges.
  • Landscape Vigilance: Continuous monitoring of national and international patents ensures competitive advantage and prevents infringement.
  • Market Strategy Integration: Patent positioning influences pricing, licensing, and market entry strategies within Peru and internationally.
  • Legal Robustness: Regular patent validity assessments and potential for strategic patent extensions sustain market exclusivity.
  • Proactive Litigation Preparedness: Understanding the regional patent environment facilitates defense against infringement suits or opposition proceedings.

FAQs

  1. What is the typical scope of pharmaceutical patents like PE20151600?
    They generally cover specific chemical structures, formulations, or manufacturing processes, with claims tailored to maximize protection while complying with patentability standards.

  2. How does claim scope influence patent enforceability?
    Broader claims provide extensive protection but are more susceptible to invalidation; narrower claims are easier to defend but offer limited exclusivity.

  3. What are the main challenges in the patent landscape for drugs in Peru?
    The primary challenges include patent overlaps with existing patents, potential for compulsory licensing, and ensuring claims are robust against prior art.

  4. How does the international patent landscape impact the Peruvian patent PE20151600?
    Having patent families in key jurisdictions enhances global protection, deters infringement, and facilitates licensing opportunities.

  5. What strategic steps should patent holders consider?
    Continuous monitoring, defensible claim drafting, timely enforcement, and exploring patent extensions or supplementary protection certificates (SPCs) are critical strategies.


References

  1. [1] INDECOPI, Peru Patent Application Database, 2015.
  2. [2] World Intellectual Property Organization (WIPO). Patent Law and Procedure.
  3. [3] TRIPS Agreement, WTO.
  4. [4] Peruvian Patent Law No. 29459, 2015.
  5. [5] Patent Landscape Reports, Global Data.

Note: Specific claim details and technical disclosures require access to the full patent document.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.